首页> 外文期刊>The journal of clinical endocrinology and metabolism >Efficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly
【24h】

Efficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly

机译:奥曲肽植入物治疗肢端肥大症的疗效和安全性

获取原文
       

摘要

Context:Acromegaly is caused by excessive GH secretion and IGF-I overproduction. The goals of treatment are to reduce GH and IGF-I values to normal and relieve the associated symptoms.
机译:背景:肢端肥大症是由过量的GH分泌和IGF-I过度生产引起的。治疗的目标是将GH和IGF-I值降低至正常水平并缓解相关症状。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号